Ghost Tree Capital as of June 30, 2015
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 66 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Allergan | 4.4 | $14M | 45k | 303.47 | |
| Flamel Technologies | 4.0 | $12M | 575k | 21.19 | |
| Biogen Idec (BIIB) | 3.9 | $12M | 30k | 403.93 | |
| NuVasive | 3.6 | $11M | 235k | 47.38 | |
| Alnylam Pharmaceuticals (ALNY) | 3.5 | $11M | 90k | 119.87 | |
| Five Prime Therapeutics | 3.4 | $11M | 425k | 24.84 | |
| Intuitive Surgical (ISRG) | 3.1 | $9.7M | 20k | 484.50 | |
| Endo International (ENDPQ) | 3.1 | $9.6M | 120k | 79.65 | |
| Gw Pharmaceuticals Plc ads | 3.0 | $9.2M | 75k | 122.84 | |
| Alexion Pharmaceuticals | 2.9 | $9.0M | 50k | 180.78 | |
| Portola Pharmaceuticals | 2.5 | $7.7M | 170k | 45.55 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.4 | $7.4M | 60k | 123.48 | |
| Horizon Pharma | 2.2 | $6.9M | 200k | 34.74 | |
| GenMark Diagnostics | 2.2 | $6.8M | 750k | 9.06 | |
| Sage Therapeutics (SAGE) | 2.1 | $6.5M | 89k | 73.01 | |
| Nanostring Technologies (NSTGQ) | 2.0 | $6.2M | 400k | 15.42 | |
| Esperion Therapeutics (ESPR) | 2.0 | $6.1M | 75k | 81.76 | |
| Cepheid | 2.0 | $6.1M | 100k | 61.15 | |
| CIGNA Corporation | 2.0 | $6.1M | 38k | 162.00 | |
| Epizyme | 1.9 | $6.0M | 250k | 24.00 | |
| Neurocrine Biosciences (NBIX) | 1.9 | $5.9M | 123k | 47.76 | |
| Amicus Therapeutics (FOLD) | 1.7 | $5.3M | 375k | 14.15 | |
| Atara Biotherapeutics (ATRA) | 1.7 | $5.3M | 100k | 52.76 | |
| Dex (DXCM) | 1.7 | $5.2M | 65k | 79.98 | |
| Aetna | 1.6 | $5.1M | 40k | 127.45 | |
| Anacor Pharmaceuticals In | 1.6 | $5.0M | 65k | 77.43 | |
| Uniqure Nv (QURE) | 1.6 | $5.0M | 185k | 27.00 | |
| Endochoice Hldgs | 1.6 | $4.9M | 300k | 16.35 | |
| Ptc Therapeutics I (PTCT) | 1.6 | $4.8M | 100k | 48.13 | |
| Cellectis S A (CLLS) | 1.5 | $4.5M | 125k | 36.08 | |
| Vanda Pharmaceuticals (VNDA) | 1.4 | $4.4M | 350k | 12.69 | |
| Zeltiq Aesthetics | 1.4 | $4.4M | 150k | 29.47 | |
| Cynapsus Therapeutics | 1.4 | $4.3M | 263k | 16.29 | |
| Ironwood Pharmaceuticals (IRWD) | 1.4 | $4.2M | 350k | 12.06 | |
| Vitae Pharmaceuticals | 1.4 | $4.2M | 289k | 14.40 | |
| Wright Medical | 1.3 | $3.9M | 150k | 26.26 | |
| Alcobra | 1.3 | $3.9M | 600k | 6.54 | |
| Sunesis Pharmaceuticals | 1.2 | $3.8M | 1.3M | 3.01 | |
| Genocea Biosciences | 1.2 | $3.7M | 270k | 13.73 | |
| Assembly Biosciences | 1.1 | $3.4M | 175k | 19.26 | |
| Anthem (ELV) | 1.1 | $3.3M | 20k | 164.15 | |
| BioDelivery Sciences International | 1.1 | $3.2M | 406k | 7.96 | |
| Rockwell Medical Technologies | 1.0 | $3.2M | 200k | 16.12 | |
| Lion Biotechnologies | 1.0 | $3.2M | 350k | 9.17 | |
| Kempharm | 1.0 | $3.2M | 175k | 18.37 | |
| Therapeuticsmd | 1.0 | $3.1M | 400k | 7.86 | |
| Axovant Sciences | 0.9 | $2.8M | 135k | 20.38 | |
| Avalanche Biotechnologies In | 0.9 | $2.7M | 165k | 16.27 | |
| Foamix Pharmaceuticals | 0.8 | $2.6M | 250k | 10.25 | |
| Puma Biotechnology (PBYI) | 0.7 | $2.0M | 18k | 116.74 | |
| Tonix Pharmaceuticls | 0.6 | $1.8M | 203k | 8.97 | |
| Radius Health | 0.6 | $1.7M | 25k | 67.72 | |
| Versartis | 0.5 | $1.5M | 100k | 15.22 | |
| Adaptimmune Therapeutics (ADAP) | 0.5 | $1.4M | 77k | 18.33 | |
| Ascendis Pharma A S (ASND) | 0.4 | $1.1M | 64k | 17.68 | |
| Unilife US | 0.3 | $968k | 450k | 2.15 | |
| Veracyte (VCYT) | 0.3 | $873k | 78k | 11.14 | |
| Nivalis Therapeutics | 0.2 | $758k | 50k | 15.16 | |
| BioCryst Pharmaceuticals (BCRX) | 0.2 | $672k | 45k | 14.93 | |
| Kindred Biosciences | 0.2 | $638k | 94k | 6.82 | |
| Biolase Technology | 0.2 | $522k | 300k | 1.74 | |
| XOMA CORP Common equity shares | 0.2 | $485k | 125k | 3.88 | |
| Ocera Therapeutics | 0.1 | $475k | 125k | 3.80 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $432k | 38k | 11.52 | |
| Glaukos (GKOS) | 0.1 | $435k | 15k | 29.00 | |
| Neothetics, Inc. Cmn | 0.1 | $387k | 43k | 9.00 |
